Pictet Asset Management
GPCR icon

Pictet Asset Management’s Structure Therapeutics GPCR Stock Holding History

Pictet Asset Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-138,797
Closed -$5.66M – 1992
2023
Q4 		$5.66M Buy
+138,797
New +$7.95M 0.01% 768

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Pictet Asset Management's GPCR Position: Q1 2024 in Review

Pictet Asset Management sold out of Structure Therapeutics (GPCR) in Q1 2024, closing a stake of 138,797 shares — an estimated $5.66M sold.

Pictet Asset Management first reported a position in GPCR in Q4 2023 and held it in 1 quarter. The position peaked at $5.66M in Q4 2023. 119 funds tracked by Wall St. Rank hold GPCR as of Q1 2024.

  • Pictet Asset Management reported no remaining Structure Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Pictet Asset Management sold 138,797 Structure Therapeutics shares in Q1 2024, an estimated $5.66M.
  • Pictet Asset Management first reported a position in Structure Therapeutics in Q4 2023 and held it in 1 quarter.
  • Pictet Asset Management's Structure Therapeutics position peaked at $5.66M in Q4 2023.
  • 119 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2024.

Based on Pictet Asset Management's 13F filing for Q1 2024, filed 14 May 2024.